Read + Share
Xu Z, Hao X, Wang Q, Yang K, et al. Intracranial efficacy and safety of furmonertinib 160 mg with or without
anti-angiogenic agent in advanced NSCLC patients with BM/LM as salvage therapy. BMC Cancer 2023;23:206.
PMID: 36870951
|
 |
|
Xu Z, Hao X, Wang Q, Yang K, et al. Intracranial efficacy and safety of furmonertinib 160 mg with or without
anti-angiogenic agent in advanced NSCLC patients with BM/LM as salvage therapy. BMC Cancer 2023;23:206.
PMID: 36870951
|
|
|
|